性别肯定治疗在BRCA1+突变的跨性别女性中的困难:一个案例报告
Ana Piñar-Gutiérrez1, Suset Dueñas Disotuar1, Irene de Lara-Rodríguez2
1UGC Endocrinología y Nutrición, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
Endocrinologia, diabetes y nutricion
|March 30, 2024
概括
对跨性别女性的性别确认护理涉及雌激素,引发了乳腺癌的担忧. 这一案例强调了在接受雌激素治疗的跨性别女性中管理与BRCA1相关的乳腺癌风险.
科学领域:
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
- 跨性别者健康 跨性别者健康
背景情况:
- 跨性别女性的性别确认治疗通常涉及长期的雌激素治疗.
- 雌激素治疗与雌激素依赖性乳腺癌的风险增加有关.
- 跨性别女性乳腺癌的发病率估计为每10万女性4.1例.
更多相关视频
08:53Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
Published on: February 17, 2011
14.7K
13:04In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose
Published on: October 14, 2015
13.1K
相关概念视频
Disorders of the Female Reproductive System
357
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
357
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
